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420a Tuesday, February 5, 2013further investigate the local nature of these bends, AFM images of HMO1-
DNA complexes are imaged to probe the behavior of these complexes as
a function of protein concentration. The results show that at lower concentra-
tions, HMO1 preferentially binds to the ends of the double helix and links
separate DNA strands. At higher concentrations HMO1 induces formation
of a complex network that reorganizes DNA. Although nucleoid associated
proteins are under intense investigation, little is known about HMO1. Our
studies suggest that HMO1 proteins may facilitate interactions between mul-
tiple DNA molecules.
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Artificial DNA looping peptides have been engineered to study the roles of
protein and DNA flexibility in controlling the geometry and stability of
protein-mediated DNA loops. The LZD (Leucine Zipper Dual-binding) pep-
tides were derived by fusing a second basic DNA binding region onto the
C-terminus of GCN4-bZip, inspired by Hollenbeck and Oakley. Two variants
with different coiled-coil lengths were designed to control the orientations of
DNA bound at each end. EMSA verified binding of two DNAs to one peptide.
Ring closure experiments demonstrated that looping requires 310 bp, much
longer than the length needed for natural loops. Variation of DNA binding
site separation over a series of constructs that all cyclize to form 862 bp mini-
circles yielded positive and negative supercoils from two possible writhed ge-
ometries anchored by loops. Periodic variation in topoisomer distributions was
modeled using canonical values for DNA persistence length and torsional
modulus. These results suggest that the
LZD proteins are much less flexible than
natural looping proteins and that short
DNA loops require protein flexibility.
Small, stable, and tunable looping peptides
may act as synthetic transcriptional regula-
tors, bridges for targeting recombination,
and components of protein-DNA
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Protein Kinase R (PKR) is a key component of the interferon-induced im-
mune pathway and is activated upon binding to viral dsRNA via sequential
dimerization and autophosphorylation. PKR contain a C-terminal kinase do-
main that acts as the catalytic center and two tandem dsRNA binding motifs.
The minimal perfect duplex RNA required to activate PKR is approximately
30 bp, but 15 bp is sufficient for the binding of one PKR monomer. PKR is
also activated by certain RNAs that contain internal loops, bulges and ter-
tiary structure elements. However, the rules that distinguish RNA activators
from those that fail to activate are not yet understood. We have developed
a model molecular ruler to directly measure the RNA length requirements
for PKR dimerization and activation across a barrier. The ruler consists of
two duplex 15 bp regions separated by a variable length region of 2’-O-
methyl modified RNA that acts as a rigid, inert barrier. Control experiments
demonstrate that PKR does not bind to 2’-O-methyl dsRNA. Two PKR
monomers bind to the ruler, independent of the length of the barrier from
15 to 5 bp. However, activation is favored at shorter barrier lengths and
PKR binding affinity is enhanced as the barrier length is reduced. We pro-
pose that PKR kinase domains are able to interact across this barrier by ex-
tension of the unstructured linker lying between the kinase domain and the
dsRNA binding motifs.
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University, Atlanta, GA, USA.The ETS family of transcription factors is widely distributed among the meta-
zoan phyla and regulates the expression of a wide range of genes. Despite their
functional diversity, all ETS proteins share a structurally conserved DNA-
binding (or ETS) domain. Given the highly overlapping sequence preferences
among ETS members, it is as yet unclear how ETS proteins achieve functional
specificity, a problem known as the ‘‘specificity conundrum.’’ Compounding
this problem is a current lack of understanding of the biophysical mechanism
of sequence selectivity among ETS binding sites. We hypothesize that the
structural conservation among ETS domains disguises physicochemical hetero-
geneity in their mechanisms of sequence recognition. We have previously dem-
onstrated that the ETS-family member PU.1 (Spi-1) recruits a cooperative
network of water-mediated contacts along the protein-DNA interface for
high-affinity binding.We have now compared the thermodynamics and kinetics
of sequence recognition between the ETS domains of PU.1 and ETS1 which
represent extremes of sequence divergence (~30% homology) in the ETS fam-
ily. We found that the thermodynamics and kinetics between the two structur-
ally conserved ETS domains are highly differentiated under physiological
conditions. More precisely, whereas high-affinity PU.1 ETS-DNA binding is
enthalpically driven against an entropic penalty, ETS1 ETS-DNA binding is
entropically driven. Kinetically, whereas ETS1 ETS associates rapidly with
a high-affinity cognate site (ka > 10
7 M1 s1), PU.1 ETS is strikingly slow
(ka ~10
4 M1 s1). This profound difference in association rate constants means
that the high-affinity PU.1 ETS-DNA complex, despite being somewhat ther-
modynamically less stable than the corresponding complex with ETS1, is sig-
nificantly longer-lived. If these differences that underlie the intrinsic
heterogeneity in site recognition by ETS proteins extend to protein-protein
and domain-domain interactions, they offer one potential biophysical resolu-
tion to the specificity conundrum.
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The viral sensorMDA5has a characteristic ability to discriminate dsRNA length
and it enables immune system to recognize long viral dsRNAs in the range of
~0.5 to 7 kb. Previous study showed that MDA5 forms filament along dsRNA
and disassemble upon ATP, but it is insufficient to explain its length specificity
as the intrinsic affinity ofMDA5 for dsRNAonlymoderately depends on dsRNA
length. We observed the details of filament formation and ATP induced disas-
sembling procedure with single molecule fluorescence imaging and found that
MDA5 utilizes a combination of end-disassembly and slow nucleation kinetics
to rapidly ‘‘discard’’ short dsRNA and suppress rebinding through single mole-
cule fluorescence experiments. In contrast, filaments on long dsRNA cycle be-
tween partial end-disassembly and elongation, by passing slow nucleation
steps. Longer and more stable filament is generated through this dynamic
rebuilding cycle to repair filament discontinuities, which are often present due
to multiple, internal nucleation events. As the length of the continuous filament
determines the stability of the MDA5:dsRNA interaction, the mechanism pro-
posed here provides an explanation for how MDA5 utilizes filament assembly
and disassembly dynamics to discriminate between self vs. non-self dsRNA.
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HIV-1 reverse transcriptase (RT) is a primary target for drug development
since it converts viral RNA into double stranded DNA that is subsequently in-
tegrated into the human genome. Nonnucleoside RT Inhibitors (NNRTIs) are
routinely included in many first-line combination antiretroviral therapies and
are also used to prevent mother-to-child transmission of HIV-1. Of note, the
mechanisms by which NNRTI inhibit HIV-1 RT remain unclear despite the
wealth of available structural and biochemical data. Furthermore, the struc-
tural mechanisms by which mutations in HIV-1 RT confer NNRTI resistance
are also inadequately understood. To elucidate these mechanisms, we com-
bined several complementary tools that included a novel fluorescence
